Epicardial fat: A new therapeutic target in psoriasis

Preetha Kamath, Gabrielle Benesh, Paolo Romanelli, Gianluca Iacobellis

Research output: Contribution to journalShort survey

2 Scopus citations


Psoriasis is a chronic inflammatory disease affecting over 8 million Americans. Importantly, patients with psoriasis are at an increased risk of developing atherosclerosis, coronary artery disease, and myocardial infarctions. Several studies have suggested that psoriasis may be an independent risk factor for cardiovascular disease given their shared inflammatory properties and pathogenic similarities. Epicardial fat is also linked to cardiovascular disease and may be an independent risk factor for atherosclerosis. It has been proposed that measuring epicardial fat tissue may serve as a useful subclinical measure of cardiovascular disease in psoriasis patients. Echocardiography has been increasingly adopted as an accurate, minimally invasive, and cost-effective measure of determining the volume and thickness of epicardial fat. Using echocardiographic measures of epicardial fat thickness as a marker of cardiovascular disease and therapeutic target in psoriasis patients may provide clinicians with a means to better manage and hopefully prevent deleterious downstream effects.

Original languageEnglish (US)
Pages (from-to)4914-4918
Number of pages5
JournalCurrent pharmaceutical design
Issue number46
StatePublished - Jan 1 2019


  • Atherosclerosis
  • Cardiovascular disease
  • Echocardiography
  • Epicardial adipose tissue
  • Epicardial fat tissue
  • Psoriasis

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Epicardial fat: A new therapeutic target in psoriasis'. Together they form a unique fingerprint.

  • Cite this